» Articles » PMID: 25972868

Single-Cell Characterization of in Vitro Migration and Interaction Dynamics of T Cells Expanded with IL-2 and IL-7

Overview
Journal Front Immunol
Date 2015 May 15
PMID 25972868
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

T cells are pivotal in the immune defense against cancers and infectious agents. To mount an effector response against cancer cells, T cells need to migrate to the cancer-site, engage in contacts with cancer cells, and perform their effector functions. Adoptive T cell therapy is an effective strategy as treatment of complications such as relapse or opportunistic infections after hematopoietic stem cell transplantations. This requires a sufficient amount of cells that are able to expand and respond to tumor or viral antigens. The cytokines interleukin (IL)-2 and IL-7 drive T cell differentiation, proliferation, and survival and are commonly used to expand T cells ex vivo. Here, we have used microchip-based live-cell imaging to follow the migration of individual T cells, their interactions with allogeneic monocytes, cell division, and apoptosis for extended periods of time; something that cannot be achieved by commonly used methods. Our data indicate that cells grown in IL-7 + IL-2 had similar migration and contact dynamics as cells grown in IL-2 alone. However, the addition of IL-7 decreased cell death creating a more viable cell population, which should be beneficial when preparing cells for immunotherapy.

Citing Articles

Human Vγ9Vδ2 T cell expansion and their cytotoxic responses against cholangiocarcinoma.

Sawaisorn P, Gaballa A, Saimuang K, Leepiyasakulchai C, Lertjuthaporn S, Hongeng S Sci Rep. 2024; 14(1):1291.

PMID: 38221530 PMC: 10788337. DOI: 10.1038/s41598-024-51794-1.


Sctensor detects many-to-many cell-cell interactions from single cell RNA-sequencing data.

Tsuyuzaki K, Ishii M, Nikaido I BMC Bioinformatics. 2023; 24(1):420.

PMID: 37936079 PMC: 10631077. DOI: 10.1186/s12859-023-05490-y.


Interleukin-2 induces extracellular matrix synthesis and TGF-β2 expression in retinal pigment epithelial cells.

Jing R, Qi T, Wen C, Yue J, Wang G, Pei C Dev Growth Differ. 2019; 61(7-8):410-418.

PMID: 31608440 PMC: 6899885. DOI: 10.1111/dgd.12630.


Inflammation-on-a-Chip: Probing the Immune System Ex Vivo.

Irimia D, Wang X Trends Biotechnol. 2018; 36(9):923-937.

PMID: 29728272 PMC: 6098972. DOI: 10.1016/j.tibtech.2018.03.011.


Bridging the gap: microfluidic devices for short and long distance cell-cell communication.

Vu T, de Castro R, Qin L Lab Chip. 2017; 17(6):1009-1023.

PMID: 28205652 PMC: 5473339. DOI: 10.1039/c6lc01367h.

References
1.
Perales M, Goldberg J, Yuan J, Koehne G, Lechner L, Papadopoulos E . Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. Blood. 2012; 120(24):4882-91. PMC: 3520625. DOI: 10.1182/blood-2012-06-437236. View

2.
Han Q, Bradshaw E, Nilsson B, Hafler D, Love J . Multidimensional analysis of the frequencies and rates of cytokine secretion from single cells by quantitative microengraving. Lab Chip. 2010; 10(11):1391-400. PMC: 3128808. DOI: 10.1039/b926849a. View

3.
Ohshima Y, Yang L, Uchiyama T, Tanaka Y, Baum P, Sergerie M . OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors. Blood. 1998; 92(9):3338-45. View

4.
Levy Y, Lacabaratz C, Weiss L, Viard J, Goujard C, Lelievre J . Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest. 2009; 119(4):997-1007. PMC: 2662568. DOI: 10.1172/JCI38052. View

5.
Rosenberg S, Yang J, White D, Steinberg S . Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response. Ann Surg. 1998; 228(3):307-19. PMC: 1191483. DOI: 10.1097/00000658-199809000-00004. View